Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:51:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:33:59.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T04:33:39.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T01:34:00.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:58:48.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information related to the safety assessment of APL-2 in patients with Geographic Atrophy, while a new version number (v2.15.0) has been added.
    Difference
    50%
    Check dated 2025-04-16T16:43:49.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.